carbidopa has been researched along with nomifensine in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (57.89) | 18.7374 |
1990's | 2 (10.53) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (31.58) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Bedard, P; Marsden, CD; Parkes, JD | 1 |
Bernardi, G; Calabresi, P; Mercuri, NB | 1 |
Männistö, PT; Törnwall, M | 1 |
Braz, S; Ferreira, TM; Silveira Filho, NG; Troncone, LR; Tufik, S | 1 |
D'Antona, N; De Leo, V; Genazzani, AR; Gioffrè, WR; Mazzullo, G; Petraglia, F; Sardelli, S | 1 |
Vertosick, FT | 1 |
D'Antona, N; Danero, S; De Leo, V; Franchi, F; Genazzani, AR; La Marca, S; Pieroni, ML; Ricci, MG; Urbani, TM | 1 |
Agnoli, A; Baldassarre, M; D'Urso, R; Del Roscio, S; Falaschi, P; Frajese, G; Mearelli, S; Rocco, A; Ruggieri, S | 1 |
Benco, R; Caldara, R; Crosignani, PG; Ferrari, C; Rampini, P; Scarduelli, C | 1 |
Camanni, F; Cocchi, D; De Leo, V; Genazzani, AR; Müller, EE; Murru, S | 1 |
Barbieri, C; Benco, R; Caldara, R; Crossignani, RM; Ferrari, C; Rampini, P; Testori, GP; Trezzi, R | 1 |
Faglia, G; Moriondo, P; Nissim, M; Travaglini, P | 1 |
Barbieri, C; Caldara, R; Crosignani, PG; Ferrari, C; Malinverni, A; Mattei, AM; Rocchetti, M | 1 |
1 review(s) available for carbidopa and nomifensine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for carbidopa and nomifensine
Article | Year |
---|---|
Nomifensine in Parkinson's disease.
Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Isoquinolines; Levodopa; Male; Middle Aged; Nomifensine; Parkinson Disease; Placebos; Trihexyphenidyl | 1977 |
Prolactin changes after administration of agonist and antagonist dopaminergic drugs in puerperal women.
Topics: Amphetamine; Carbidopa; Dopamine; Dopamine Antagonists; Female; Humans; Levodopa; Nomifensine; Postpartum Period; Pregnancy; Prolactin; Receptors, Dopamine | 1987 |
Central nervous system and pituitary mechanisms in dopaminergic stimulation of growth hormone release in women.
Topics: Adolescent; Adult; Carbidopa; Central Nervous System; Dopamine; Female; Growth Hormone; Humans; Levodopa; Nomifensine; Pituitary Gland; Receptors, Dopamine | 1981 |
15 other study(ies) available for carbidopa and nomifensine
Article | Year |
---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Actions of levodopa on rat substantia nigra zona compacta neurons.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Cocaine; Female; Levodopa; Male; Neurons; Nomifensine; Rats; Rats, Wistar; Substantia Nigra; Sulpiride | 1992 |
Acute toxicity of three new selective COMT inhibitors in mice with special emphasis on interactions with drugs increasing catecholaminergic neurotransmission.
Topics: Amphetamine; Animals; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catecholamines; Catechols; Clorgyline; Convulsants; Desipramine; Drug Interactions; Lethal Dose 50; Levodopa; Male; Mice; Motor Activity; Nitriles; Nomifensine; Pentanones; Selegiline; Synaptic Transmission; Yohimbine | 1991 |
Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments.
Topics: Aggression; Amphetamine; Animals; Apomorphine; Bromocriptine; Carbidopa; Dopamine; Imipramine; Levodopa; Male; Nomifensine; Rats; Rats, Inbred Strains; Sleep Deprivation; Sleep, REM; Stereotyped Behavior | 1988 |
Role of defective dopaminergic inhibition of prolactin secretion in the pathogenesis of prolactinoma.
Topics: Autoantibodies; Carbidopa; Dopamine; Female; Humans; Hypothalamo-Hypophyseal System; Levodopa; Metoclopramide; Monoiodotyrosine; Neural Inhibition; Nomifensine; Pituitary Neoplasms; Prolactin; Radioligand Assay; Receptors, Dopamine | 1985 |
[Various aspects of dopaminergic function in patients with prolactin-secreting hypophyseal adenoma].
Topics: Adenoma; Adult; Amenorrhea; Carbidopa; Dopamine; Female; Humans; Levodopa; Nomifensine; Pituitary Neoplasms; Prolactin | 1983 |
Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study.
Topics: Aged; Apomorphine; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Nomifensine; Parkinson Disease; Prolactin; Receptors, Dopamine; Selegiline; Tremor | 1980 |
Functional characterization of hypothalamic hyperprolactinemia.
Topics: Adult; Aged; Carbidopa; Child; Dopamine; Female; Humans; Hypothalamic Diseases; Levodopa; Male; Meningeal Neoplasms; Middle Aged; Nomifensine; Pituitary Neoplasms; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1982 |
Dynamic tests of prolactin secretion in hyperprolactinemic states: carbidopa-L-dopa and indirectly acting dopamine agonists.
Topics: Adenoma; Adult; Carbidopa; Dopamine; Female; Humans; Kinetics; Levodopa; Methylphenidate; Nomifensine; Pituitary Neoplasms; Postpartum Period; Pregnancy; Prolactin | 1982 |
Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states.
Topics: Adenoma; Adolescent; Adult; Carbidopa; Diagnosis, Differential; Female; Humans; Isoquinolines; Levodopa; Male; Middle Aged; Nomifensine; Pituitary Neoplasms; Polycystic Ovary Syndrome; Prolactin | 1980 |
Effect of central nervous system dopaminergic activation on prolactin secretion in man: evidence for a common central defect in hyperprolactinemic patients with and without radiological signs of pituitary tumors.
Topics: Adolescent; Adult; Carbidopa; Female; Humans; Kinetics; Levodopa; Nomifensine; Pituitary Neoplasms; Prolactin | 1980 |